Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) were first detected
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Over the past few years, new-generation cell-based assays have demonstrated a robust
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
We sought to define the pathological features of myelin oligodendrocyte glycoprotein (MOG)
antibody associated disorders (MOGAD) in an archival autopsy/biopsy cohort. We …
antibody associated disorders (MOGAD) in an archival autopsy/biopsy cohort. We …
International multicenter examination of MOG antibody assays
Objective To compare the reproducibility of 11 antibody assays for immunoglobulin (Ig) G
and IgM myelin oligodendrocyte glycoprotein antibodies (MOG-IgG and MOG-IgM) from 5 …
and IgM myelin oligodendrocyte glycoprotein antibodies (MOG-IgG and MOG-IgM) from 5 …
Neurological update: MOG antibody disease
R Wynford-Thomas, A Jacob, V Tomassini - Journal of neurology, 2019 - Springer
Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOG-AD) is now recognised
as a nosological entity with specific clinical and paraclinical features to aid early diagnosis …
as a nosological entity with specific clinical and paraclinical features to aid early diagnosis …
MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder
R Narayan, A Simpson, K Fritsche, S Salama… - Multiple sclerosis and …, 2018 - Elsevier
MOG antibody disease is an autoimmune disease of the central nervous system associated
with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a …
with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a …
Defining distinct features of anti-MOG antibody associated central nervous system demyelination
MS Weber, T Derfuss, I Metz… - Therapeutic advances in …, 2018 - journals.sagepub.com
Extensive research over the last decades basically failed to identify a common cause of
noninfectious inflammatory central nervous system (CNS) demyelinating disease. To a great …
noninfectious inflammatory central nervous system (CNS) demyelinating disease. To a great …
Difference in the source of anti-AQP4-IgG and anti-MOG-IgG antibodies in CSF in patients with neuromyelitis optica spectrum disorder
T Akaishi, T Takahashi, T Misu, K Kaneko, Y Takai… - Neurology, 2021 - AAN Enterprises
Objective To elucidate the differences in the source and in the level of intrathecal synthesis
between anti–aquaporin-4 antibodies (AQP4-IgG) and anti-myelin oligodendrocyte …
between anti–aquaporin-4 antibodies (AQP4-IgG) and anti-myelin oligodendrocyte …